WING Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Wingstop Inc. (WING) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown positive financial growth in Q3 2025, the technical indicators suggest bearish momentum, and analysts have recently downgraded the stock due to concerns about near-term sales trends. Additionally, the options data and trading sentiment do not indicate a strong bullish outlook. Considering the investor's preference for long-term investments, it would be prudent to hold off on buying until there is more clarity on the company's performance and market conditions improve.
The technical indicators for WING show bearish momentum. The MACD histogram is negative and expanding (-5.923), the RSI is at 25.178 (neutral zone), and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key support levels (S1: 228.862, S2: 212.545), indicating potential further downside risk.
Hedge funds are significantly increasing their positions in WING, with a 1319.09% increase in buying activity over the last quarter.
The company's Q3 2025 financials show YoY growth in revenue (+8.15%), net income (+10.67%), EPS (+15.91%), and gross margin (+0.55%).
Analysts like Melius Research see long-term growth potential through international expansion and the company's asset-light model.
Recent downgrades from TD Cowen and Raymond James highlight concerns about near-term sales trends and challenges with core consumers.
Same-store sales declined by 5.6% in Q3 2025, raising doubts about the company's ability to sustain growth in the short term.
The stock is trading in a bearish trend, with key support levels broken and negative momentum in technical indicators.
Wingstop's Q3 2025 financials showed solid YoY growth: Revenue increased by 8.15% to $175.7M, net income rose by 10.67% to $28.48M, EPS grew by 15.91% to $1.02, and gross margin improved slightly to 82.34%. However, same-store sales declined by 5.6%, which is a concern for future growth.
Analyst sentiment is mixed to negative. Recent downgrades from TD Cowen (Hold, PT $285) and Raymond James (Outperform, PT $325) highlight near-term risks. However, some analysts like Melius Research upgraded the stock to Buy with a $350 price target, citing long-term growth potential. Overall, the consensus reflects caution due to near-term challenges despite optimism for the second half of 2026.
